Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and Tamoxifen in Advanced Breast Cancer
NCT00365599Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Feb 2006
- Primary completion
- Apr 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in breast cancer, sponsored by Moffitt Cancer Center. Started Feb 2006; status: completed.
02
Drugs
vorinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00365599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365599.